% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hoenig:916872,
author = {Hoenig, Merle C. and Dzialas, Verena and Drzezga, Alexander
and van Eimeren, Thilo},
title = {{T}he {C}oncept of {M}otor {R}eserve in {P}arkinson's
{D}isease: {N}ew {W}ine in {O}ld {B}ottles?},
journal = {Movement disorders},
volume = {38},
number = {1},
issn = {0885-3185},
address = {New York, NY},
publisher = {Wiley},
reportid = {FZJ-2023-00164},
pages = {16-20},
year = {2023},
abstract = {Across neurodegenerative diseases, such as Parkinson's
disease (PD) and Alzheimer's disease (AD), a disparity
between the clinical expression and the extent of
pathophysiological burden has been observed. This has fueled
the establishment of resilience concepts such as cognitive
reserve (CR) and brain reserve (BR) at the beginning of this
millennium.1 Since the introduction of these concepts, a
plethora of studies have aimed at identifying mechanisms
predominantly associated with the mitigation of cognitive
decline despite neurodegenerative changes associated with
multiple sclerosis, dementia, or healthy aging (ie,
resilience).2, 3 In comparison, resilience mechanisms in PD
have received far less attention even though they seem
equally important given the clinical heterogeneity and long
prodromal phase. With the emerging concept of motor reserve
(MR), new avenues have opened up focusing on potential
neuronal processes providing resilience (ie, relative
preservation of motor function) in PD, which can potentially
be harnessed for interventional therapies. Importantly, this
requires a common understanding of the principles of how to
assess resilience in observational studies and how to
quantify its underlying mechanisms. Given the head start in
identifying pitfalls and precisely delineating the concept
of resilience in the AD field, the opportunity lies at hand
to benefit from this knowledge for investigations of MR in
PD.},
cin = {INM-2},
ddc = {610},
cid = {I:(DE-Juel1)INM-2-20090406},
pnm = {5252 - Brain Dysfunction and Plasticity (POF4-525)},
pid = {G:(DE-HGF)POF4-5252},
typ = {PUB:(DE-HGF)16},
pubmed = {36345092},
UT = {WOS:000879614200001},
doi = {10.1002/mds.29266},
url = {https://juser.fz-juelich.de/record/916872},
}